Skip to content

Effects of Patient Control Intravenous Analgesia (PCIA) on Breast Milk and Newborns

Effects of Patient Control Intravenous Analgesia (PCIA) on Breast Milk and Newborns

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019751
Enrollment
Unknown
Registered
2018-11-26
Start date
2018-11-26
Completion date
Unknown
Last updated
2018-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain after cesarean section

Interventions

PCIA group:PCIA used after cesarean section (fentanyl + dizosin + butorphanol)
contrast group:spontaneous labor without analgesia

Sponsors

Shanghai First People's Hospital, Baoshan Branch
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
16 Years to 46 Years

Inclusion criteria

Inclusion criteria: The participants were all American Society of Anaesthesiologists physical status classification I(healthy) or II (well-controlled medically). Mothers were either scheduled for elective CB at 37 or more weeks of gestation, and had consented to combined spinal-epidural anaesthesia with PCIA for postoperative analgesia, or had delivered vaginally with no opioid patient-controlled epidural analgesia.

Exclusion criteria

Exclusion criteria: Neonatal APGAR score was less than 10.

Design outcomes

Primary

MeasureTime frame
Concentrations of protein, lactose, sodium and potassium in breast milk at 0-72 h and 72-120 h;analgesic drugs content in the blood, urine, breast milk of parturients after cesarean section and the urine of newborns;Neonatal neuroadaptability scores (NACS) at 24, 48 and 72 hours after delivery;

Countries

China

Contacts

Public ContactWenyi Gong

Shanghai First People's Hospital, Baoshan Branch

gong.wy@hotmail.com+86 13816983539

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026